Market closed

Medifast/$MED

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Medifast

Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

Ticker

$MED

Sector

Consumer Staples

Trading on

NYSE

Industry

Personal Care Products

Headquarters

Baltimore, United States

Employees

634

Website

medifastinc.com

Medifast Metrics

BasicAdvanced

$167M

23.60 $0.67

1.16 -

Price and volume

Market cap

$167M

Beta

1.16

52-week high

$61.07

52-week low

$15.10

Average daily volume

251K

Financial strength

Current ratio

3.108

Quick ratio

2.348

Long term debt to equity

5.556

Total debt to equity

8.5

Dividend payout ratio (TTM)

255.19%

Management effectiveness

Return on assets (TTM)

4.77%

Return on equity (TTM)

3.66%

Valuation

Price to earnings (TTM)

23.598

Price to revenue (TTM)

0.254

Price to book

0.81

Price to tangible book (TTM)

0.81

Price to free cash flow (TTM)

5.071

Growth

Revenue change (TTM)

-44.64%

Earnings per share change (TTM)

-93.92%

3-year revenue growth (CAGR)

-21.85%

3-year earnings per share growth (CAGR)

-63.18%

What the Analysts think about Medifast

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Medifast stock.

Medifast Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Medifast Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Medifast News

AllArticlesVideos

Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued

Seeking Alpha·2 months ago

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Business Wire·3 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MED

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Medifast stock?

Medifast (MED) has a market cap of $167M as of January 15, 2025.

What is the P/E ratio for Medifast stock?

The price to earnings (P/E) ratio for Medifast (MED) stock is 23.6 as of January 15, 2025.

Does Medifast stock pay dividends?

No, Medifast (MED) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Medifast dividend payment date?

Medifast (MED) stock does not pay dividends to its shareholders.

What is the beta indicator for Medifast?

Medifast (MED) has a beta rating of 1.16. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.